Scribe Therapeutics IPO Closing Market Cap: how this market works

What you need to know

This market is asking how much Scribe Therapeutics will be worth when it first starts trading on a stock exchange. Market capitalization, or 'market cap', is simply the total value the stock market puts on a company on day one: the share price times the number of shares. A Yes to the top bracket means the market values Scribe at $145 million or more on that first trading day. The other brackets cover smaller outcomes, and one option covers the IPO not happening at all before September 2026. The market settles based on Scribe's official closing share price on its first day of trading, multiplied by the total number of shares outstanding, pulled from SEC filings and the exchange's official page. The IPO is currently scheduled for July 24, 2026. If it does not happen by August 31, 2026, the market resolves to 'No IPO before September 2026'. One edge case worth knowing: if trading is interrupted on day one, the market uses whatever official closing price exists, even from a shortened session. No relevant recent news was provided for this market. The kinds of developments worth watching for would be Scribe filing updated pricing documents with the SEC, any changes to the IPO timeline, or broader shifts in appetite for biotech IPOs in general, since market conditions strongly influence how new listings are priced and received. The market prices the $145M-plus outcome at around 89%, so the main uncertainty is not really 'which bracket wins' but rather whether something unexpected disrupts that outcome. IPO pricing can shift in the final days before listing based on investor demand, market conditions, or company decisions. The IPO could also be delayed or pulled entirely, which is a small but real possibility the 4% 'No IPO' bracket reflects. Biotech valuations are also sensitive to news that can move quickly.

The odds right now

• $145M+88%
• No IPO before September 20264%
• $130M-$145M2%
• $85M-$100M2%
• $100M-$115M2%
• $115M-$130M2%
• <$85M1%

Price history

How this resolves

Resolves July 24, 2026

This market will resolve based on Scribe Therapeutics' market capitalization at the closing price on its first day of trading. As of market creation, the IPO is scheduled to price on July 24 (ET). Read the full resolution rules on the live market page.

Related

Same markets. A fraction of the fee.

These apps all route to the same exchange order book. The difference is what each one adds on top of the exchange's own fee.

Published rates, checked July 2026. MetaMask charges a flat 4 percent per prediction trade. Jupiter adds a fee equal to the exchange's own taker fee at fill time, roughly 2 to 4 percent at typical odds. Where a market carries an exchange settlement fee, it applies everywhere, whichever app you use. Paridesk adds nothing on maker orders.

Trade this market on Paridesk: non-custodial, 0.5% fee.